For years PBMs have been assailed by pharma companies and Congress, and the new Trump administration looks likely to keep up the barrage.
CVS CEO David Joyner's comments come as lawmakers on both sides of the aisle and President Donald Trump have signaled ...
Outrage against PBMs was on full display when 400 pharmacy professionals in Kansas shuttered their businesses and petitioned ...
A U.S. judge ordered federal agencies to restore access to health-related webpages and datasets removed by the Trump ...
CVS Health reported $1.6 billion in profit for the fourth quarter, down from a $2 billion haul a year ago, according to its ...
On the revenue side, PBMs get paid by insurance companies to secure rebates from drugmakers in exchange for favorable ...
As prescription drug prices continue to spiral and federal efforts to control them stall, state lawmakers are focusing on ...
CVS CEO David Joyner just finished his first full quarter at the helm. He spoke with Yahoo Finance about the conservative ...
We spoke recently with Craig Burton, MBA, executive director of the Biosimilars Council, a trade and lobbying group for the ...
Express Scripts Inc. lost its bid to toss antitrust claims in a case alleging it conspired with other benefit managers to fix pharmacy reimbursement rates, as a federal judge found the plaintiffs ...
Ken Paxton's opinion puts Texas on a collision course with employer groups that say ERISA should shield the plans from the ...